Skip to main content
. 2017 Aug 24;61(9):e01015-17. doi: 10.1128/AAC.01015-17

FIG 1.

FIG 1

Goodness-of-fit plots of the final population pharmacokinetic model for teicoplanin in 10 patients who received venoarterial extracorporeal membrane oxygenation. Observed teicoplanin concentrations versus population predicted concentrations (A) and individual predicted concentrations (B) and conditional weighted residuals versus population predicted concentrations (C) and time (D) are shown.